Investing in Eagle Pharmaceuticals, Inc. (EGRX)

Valuation methodValue, $Upside, %
Artificial intelligence (AI)45.05922
Intrinsic value (DCF)44.47908
Graham-Dodd Method19.08333
Graham Formula0.00-100

Company description

Eagle Pharmaceuticals Inc. (ticker symbol EGRX) is a specialty pharmaceutical company that primarily focuses on developing and commercializing injectable products for the treatment of complex and high-value diseases. Founded in 2007 and based in Woodcliff Lake, New Jersey, the company has established itself as a leader in the niche market of injectable products, with over 10 approved FDA products and a robust pipeline of investigational drugs in various stages of development. Their products range from oncology and critical care treatments to specialty drugs for rare diseases, addressing critical unmet medical needs in the market. Eagle Pharmaceuticals prides itself on its innovative approach to drug development, utilizing its proprietary technology and expertise to improve existing products and bring new ones to market. In addition to their focus on injectable products, the company also has a growing presence in the over-the-counter (OTC) market, with partnerships and licensing agreements in place to expand their global reach. With a strong track record of growth and a dedicated team of professionals, Eagle Pharmaceuticals is well-positioned for continued success in the pharmaceutical industry.